08/25/2025 3:39 PM | Acrivon Therapeutics (Issuer) Blume-Jensen Peter (Reporting) Masson Kristina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/18/2025 4:14 PM | Acrivon Therapeutics (Issuer) Blume-Jensen Peter (Reporting) Masson Kristina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/13/2025 10:12 AM | Acrivon Therapeutics (Subject) Sands Capital Life Sciences Pulse Fund II, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
06/17/2025 7:17 PM | Acrivon Therapeutics (Issuer) Kolchinsky Peter (Reporting) RA Capital Healthcare Fund LP (Reporting) RA CAPITAL MANAGEMENT, L.P. (Reporting) RA Capital Nexus Fund II, L.P. (Reporting) Shah Rajeev M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2025 4:48 PM | Acrivon Therapeutics (Issuer) Magovcevic-Liebisch Ivana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2025 4:49 PM | Acrivon Therapeutics (Issuer) Palani Santhosh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2025 4:54 PM | Acrivon Therapeutics (Issuer) Shacham Sharon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2025 4:57 PM | Acrivon Therapeutics (Issuer) TOMSICEK MICHAEL JOHN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2025 5:04 PM | Acrivon Therapeutics (Issuer) DiRocco Derek (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2025 4:21 PM | Acrivon Therapeutics (Issuer) BAUM CHARLES M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2025 3:05 PM | Acrivon Therapeutics (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for ACRV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
05/23/2025 3:58 PM | Acrivon Therapeutics (Issuer) Blume-Jensen Peter (Reporting) Masson Kristina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2025 4:24 PM | Acrivon Therapeutics (Subject) CITADEL ADVISORS LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/14/2025 3:47 PM | Acrivon Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/14/2025 3:16 PM | Acrivon Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/01/2025 7:21 PM | Acrivon Therapeutics (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/01/2025 6:07 PM | Acrivon Therapeutics (Issuer) EDELMAN JOSEPH (Reporting) PERCEPTIVE ADVISORS LLC (Reporting) PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2025 6:26 PM | Acrivon Therapeutics (Issuer) EDELMAN JOSEPH (Reporting) PERCEPTIVE ADVISORS LLC (Reporting) PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/25/2025 7:34 AM | Acrivon Therapeutics (Filer)
| Form ARS | |
04/25/2025 7:30 AM | Acrivon Therapeutics (Filer)
| Form DEF 14A | |
04/25/2025 7:32 AM | Acrivon Therapeutics (Filer)
| Form DEFA14A | |
04/21/2025 3:22 PM | Acrivon Therapeutics (Issuer) Mirza Mansoor Raza (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/03/2025 3:32 PM | Acrivon Therapeutics (Issuer) Miller Mary (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2025 3:28 PM | Acrivon Therapeutics (Issuer) Levy Adam D. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/03/2025 3:30 PM | Acrivon Therapeutics (Issuer) Levy Adam D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2025 8:08 AM | Acrivon Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/27/2025 3:48 PM | Acrivon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/25/2025 4:15 PM | Acrivon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/14/2025 3:44 PM | Acrivon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/04/2025 4:36 PM | Acrivon Therapeutics (Issuer) Peterson Katharine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 4:28 PM | Acrivon Therapeutics (Issuer) Holm-Jorgensen Rasmus (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 4:31 PM | Acrivon Therapeutics (Issuer) Miller Mary (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/19/2025 3:52 PM | Acrivon Therapeutics (Issuer) Blume-Jensen Peter (Reporting) Masson Kristina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/19/2025 3:53 PM | Acrivon Therapeutics (Issuer) Devroe Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/19/2025 3:54 PM | Acrivon Therapeutics (Issuer) Gamelin Erick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/19/2025 3:55 PM | Acrivon Therapeutics (Issuer) Holm-Jorgensen Rasmus (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/19/2025 3:59 PM | Acrivon Therapeutics (Issuer) Miller Mary (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2024 5:04 PM | Acrivon Therapeutics (Issuer) Blume-Jensen Peter (Reporting) Masson Kristina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2024 5:06 PM | Acrivon Therapeutics (Issuer) Devroe Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2024 5:08 PM | Acrivon Therapeutics (Issuer) Gamelin Erick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2024 5:10 PM | Acrivon Therapeutics (Issuer) Holm-Jorgensen Rasmus (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis (Ad) With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing.
Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis. Claim your free copy of “How to Survive the Next Financial Crisis” today |
11/27/2024 5:11 PM | Acrivon Therapeutics (Issuer) Miller Mary (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2024 6:06 AM | Acrivon Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024 6:00 AM | Acrivon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/21/2024 3:22 PM | Acrivon Therapeutics (Issuer) Miller Mary (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/11/2024 7:00 AM | Acrivon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/03/2024 5:49 PM | Acrivon Therapeutics (Issuer) Miller Mary (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2024 5:43 AM | Acrivon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |